| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.41B | -7.4% |
| Cost of Revenue | $1.91B | -10.4% |
| R&D Expense | $321.0M | -13.0% |
| SG&A Expense | $1.26B | -9.9% |
| Interest Expense | $241.0M | +2.1% |
| Pre-tax Income | -$72.0M | +87.3% |
| Income Tax | $6.0M | +106.3% |
| Net Income | -$78.0M | +83.5% |
| EPS (Basic) | -$0.16 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $345.0M | -45.9% |
| Accounts Receivable | $797.0M | -4.3% |
| Inventory | $1.54B | +12.0% |
| Current Assets | $3.28B | +0.1% |
| Total Assets | $15.49B | -6.0% |
| Current Liabilities | $1.70B | +3.6% |
| Long-term Debt | $5.84B | -7.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $452.0M | -6.4% |
| Capital Expenditures | $137.0M | +8.7% |
| Investing Cash Flow | -$179.0M | +66.2% |
| Financing Cash Flow | -$549.0M | -361.4% |
| Free Cash Flow | $315.0M | -11.8% |
| +83.5% |
| EPS (Diluted) | -$0.16 | +83.5% |
| Total Liabilities |
| $8.20B |
| -8.3% |
| Stockholders' Equity | $7.29B | -3.3% |